Effect of recombinant human erythropoietin on renal function in humans

This publication has 16 references indexed in Scilit:

• Recombinant Human Erythropoietin Treatment in Pre-Dialysis Patients
  Annals of Internal Medicine, 1989
• Treatment of the Anemia of Predialysis Patients with Recombinant Human Erythropoietin: A Randomized, Placebo-Controlled Trial
  The Lancet Healthy Longevity, 1988
• Anemia lessens and its prevention with recombinant human erythropoietin worsens glomerular injury and hypertension in rats with reduced renal mass.
  Proceedings of the National Academy of Sciences, 1988
• Efficacy and Side Effects of Erythropoietin Used in the Treatment of Anemia of Uremic Rats
  Published by S. Karger AG ,1987
• Correction of the Anemia of End-Stage Renal Disease with Recombinant Human Erythropoietin
  New England Journal of Medicine, 1987
• EFFECT OF HUMAN ERYTHROPOIETIN DERIVED FROM RECOMBINANT DNA ON THE ANAEMIA OF PATIENTS MAINTAINED BY CHRONIC HAEMODIALYSIS
  The Lancet, 1986
• Effects of dietary protein and phosphorus restriction on the progression of early renal failure
  Kidney International, 1982
• A SIMPLE METHOD OF ESTIMATING PROGRESSION OF CHRONIC RENAL FAILURE
  The Lancet, 1976
• Dynamics of glomerular ultrafiltration in the rat. VIII. Effects of hematocrit.
  Circulation Research, 1975
• Effects of hematocrit on renal hemodynamics and sodium excretion in hydropenic and volume-expanded dogs
  Journal of Clinical Investigation, 1970